The study concluded that elevated sFas combined with CA125 levels (mean 16.6 U/mL in benign tumors vs. 343 U/mL in malignant tumors) could aid in distinguishing benign ovarian cysts from ovarian cancer [49]. This evidence concerns the gene MUC16 and ovarian carcinoma.